What makes something alive? We simply don't know, but synthetic biologists are a step closer to providing an answer thanks to ...
The ICSE board has released the latest class 9 syllabus for the new 2026-27 academic session. With the help of the syllabus, ...
NCERT’s latest textbook changes under NEP 2020—from adding the 1975–77 Emergency to reducing Mughal history, revising Gandhi assassination references, dropping evolution and Gujarat riots content—have ...
Be Biopharma’s terminated trial is the latest setback in the hemophilia space, where companies like Pfizer and BioMarin have opted to pull their respective products from the market after weak traction ...
NEW DELHI: In a swift move, National Council of Educational Research and Training (NCERT) decided to restore the original version of the iconic “Dancing Girl” of Mohenjo-daro in its new class IX ...
Meet the valedictorians and salutatorians from Palm Beach County high schools. Alexander W. Dreyfoos School of the Arts, West Palm Beach Valedictorian Scarlett Huang Hometown: Boca Raton GPA ...
At a Dec. 1, 2023 news conference, Oregon beach volleyball player Batia Rotshtein speaks to reporters alongside attorney Arthur Bryant, right, rowing club captain Elise Haverland, left, beach ...
Oregon beach volleyball’s ongoing lawsuit against the university can no longer proceed as a class action case, a judge ruled late last month. In a May 28 order, U.S. district judge Michael McShane ...
EULAR data demonstrated potential for immune reset, including remissions, in both systemic lupus erythematosus (SLE) and ...
CHICAGO--(BUSINESS WIRE)--Syntax Bio, a synthetic biology company programming next generation cell therapies, today announced a research and development collaboration with Mayo Clinic focused on ...
William Parks is a Game Rant editor who specializes in puzzle games, indie releases, Nintendo titles, and completion-focused guide coverage. Since joining Game Rant in 2019, he has written and edited ...
Johnson & Johnson JNJ1.61%increase; up pointing triangle has agreed to buy biotechnology company Firefly Bio for $1 billion in cash in a deal that bolsters the drugmaker’s oncology pipeline. J&J on ...